Search Results 11-20 of 17506 for Liposome

  1. A Study to Evaluate the Effectiveness and Safety of an Amikacin Liposome Inhalation Suspension-based Regimen in Adults with Nontuberculous Mycobacterial Lung Infection - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of ALIS + azithromycin (AZI) + ethambutol (ETH) compared to the empty liposome control (ELC) + AZI + ...

  2. Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors - Mayo Clinic

    Liposomal irinotecan and veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation eligibility.

  3. Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer - Mayo Clinic

    Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or ...

  4. A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection - Mayo Clinic

    A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...

  5. Liposomal Cytarabine-Daunorubicin CPX-351, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

    Liposomal cytarabine-daunorubicin CPX-351 is made up of two chemotherapy drugs, cytarabine and daunorubicin hydrochloride, and works to stop cancer cell growth ...

  6. A Study to Evaluate Wound Infiltration with Liposomal Bupivacaine in Laparotomy for Gynecological Malignancy - Mayo Clinic

    ... (liposomal bupivacaine) injection for pain management after abdominal surgery for gynecological cancer. Participation eligibility. Participant eligibility ...

  7. Postoperative Analgesia after Breast Reduction Surgery Comparing Liposomal Bupivacaine versus 0.25% Bupivacaine Hydrochloride - Mayo Clinic

    The purpose of this study is to compare liposomal bupivacaine and 0.25% Bupivacaine Hydrochloride as local infiltration. Participation eligibility.

  8. Loco-Regional Liposomal Bupivacaine Injection in Lower Extremity Revascularization - Mayo Clinic

    The purpose of this study is to compare loco-regional liposomal bupivacaine injection versus normal saline (placebo control group) to assess possible reduction ...

  9. A Study for Women who have Platinum Resistant Ovarian Cancer to Evaluate EC145 Combined with Pegylated Liposomal Doxorubicin, Compared to Pegylated Liposomal Doxorubicin Alone - Mayo Clinic

    ... Liposomal Doxorubicin, Compared to Pegylated Liposomal Doxorubicin Alone ... liposomal doxorubicin (EC145+PLD) with those who receive PLD alone.

  10. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

    Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast ...